Results 1 to 10 of about 27,587 (242)

The effects of neoadjuvant chemoradiotherapy-related frailty by analytic morphomics in esophageal cancer [PDF]

open access: yesJournal of Cardiothoracic Surgery
Background Neoadjuvant chemoradiotherapy followed by surgery offers potential cure for locally advanced esophageal cancer. Yet, frailty often emerges post-therapy, heightening risks of delayed surgery and complications.
Chien-Hung Chiu   +10 more
doaj   +2 more sources

Neoadjuvant chemoradiotherapy for resectable gastric cancer: A meta-analysis

open access: yesFrontiers in Oncology, 2022
ObjectivesTo evaluate the clinical curative effects and toxicity of neoadjuvant chemoradiotherapy for resectable gastric cancer compared to those of neoadjuvant chemotherapy.MethodsA systematic review and meta-analysis of the randomized controlled trials
Jiuzhou Chen   +13 more
doaj   +3 more sources

Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for locally advanced gastric cancer: a systematic review and meta-analysis

open access: yesFrontiers in Oncology, 2023
BackgroundThere is increasing evidence that neoadjuvant chemoradiotherapy is superior to neoadjuvant chemotherapy for patients with locally advanced gastric cancer. However, a number of studies have come to the opposite conclusion.
Youqi Zhu   +13 more
doaj   +1 more source

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder [PDF]

open access: yesInvestigative and Clinical Urology, 2022
Purpose: To assess the safety and efficacy of gemcitabine and cisplatin as neoadjuvant chemotherapy followed by selective bladder preservation chemoradiotherapy in muscle-invasive bladder cancer (MIBC).
Hyun Hwan Sung   +8 more
doaj   +1 more source

Impacts of neoadjuvant therapy on the number of dissected lymph nodes in esophagogastric junction cancer patients

open access: yesBMC Gastroenterology, 2023
Background Neoadjuvant therapy favors the prognosis of various cancers, including esophagogastric junction cancer (EGC). However, the impacts of neoadjuvant therapy on the number of dissected lymph nodes (LNs) have not yet been evaluated in EGC.
Qi Wang   +4 more
doaj   +1 more source

Case Report: Neoadjuvant PD-1 Blockade Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Gastric Cancer Patients

open access: yesFrontiers in Oncology, 2021
Programmed death 1(PD-1) blockade has shown promising efficacy in advanced gastric cancer. Here, we performed a retrospective analysis of three patients with locally advanced gastric cancer who received adjuvant PD-1 plus chemoradiotherapy as neoadjuvant
Jia Wei   +12 more
doaj   +1 more source

Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial

open access: yesBMC Cancer, 2023
Background The failure rate after neoadjuvant chemoradiotherapy followed by surgery is approximately 34.6%–48% for resectable esophageal carcinoma. Pathologic complete response after neoadjuvant chemoradiotherapy is an important factor in predicting ...
Jinsong Yang   +3 more
doaj   +1 more source

Effects of Neoadjuvant Chemio-Radiation Therapy on the Anal Sphincter Function in Patients with Low Rectal Cancers

open access: yesКреативная хирургия и онкология, 2020
The aim of the study was to compare functional results prior to and following neoadjuvant chemoradiation therapy.Materials and methods. An analysis of the functional results of a prospective clinical study was carried out.
A. B. Baichorov, A. O. Rasulov
doaj   +1 more source

Management of Clinically Involved Lateral Lymph Node Metastasis in Locally Advanced Rectal Cancer: A Radiation Dose Escalation Study

open access: yesFrontiers in Oncology, 2021
BackgroundPatients with lateral lymph nodes (LLNs) metastasis are not effectively treated with neoadjuvant chemoradiotherapy. This study aimed to compare the efficacy of three neoadjuvant therapeutic regimens, namely, chemotherapy, chemoradiotherapy, and
Xiaolin Pang   +17 more
doaj   +1 more source

Survival benefit of adding chemotherapy to intensity modulated radiation in patients with locoregionally advanced nasopharyngeal carcinoma. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND:To evaluate the contribution of chemotherapy for patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated by intensity modulated radiotherapy (IMRT) and to identify the optimal combination treatment strategy.
Xuemei Ji   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy